The relationship between rheumatoid arthritis (RA) and psychiatric disorder
DOI:
https://doi.org/10.12775/QS.2025.43.61176Keywords
rheumatoid arthritis, psychiatric disorders, depression, anxietyAbstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease that has a destructive effect on the joints, but also leads to many systemic complications, including mental disorders. This review will present the co-occurrence of mood disorders, such as depression, anxiety and cognitive disorders, in patients with RA and analyze the potential pathophysiological mechanisms. The impact of chronic inflammation and proinflammatory cytokines (IL-6, IL-1β, TNF-α) on the central nervous system and the hypothalamic-pituitary-adrenal axis (HPA) will be discussed. When rheumatoid arthritis (RA) is accompanied by mental health disorders, treatment methods used for RA may be less effective. This can make the condition harder to manage, increasing pain and reducing the quality of life. Additionally, the paper will present the impact of pain, fatigue and reduced physical fitness on the deterioration of the mental health of patients. In addition to the pharmacological treatment used for RA, which is also not neutral to patient’s health, additional therapeutic options such as psychological interventions will be discussed. Considering both somatic and psychological aspects, an interdisciplinary approach to the treatment of patients with RA is very important.
References
[1] Yun-Hong Cheon ,Seung-Geun Lee, Mingyo Kim, Hyun-Ok Kim, Young Sun Suh, Ki-Soo Park; The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis;
[2] Jang S, Kwon EJ, Lee JJ. Rheumatoid arthritis: pathogenic roles of diverse immune cells. Int J Mol Sci. 2022;23(2):905. doi:10.3390/ijms23020905. PMID: 35055410
[3] Miguel-Lavariega D, Elizararrás-Rivas J, Villarreal-Ríos E, Baltiérrez-Hoyos R, Velasco-Tobón U, Vargas-Daza ER, Galicia-Rodríguez L. Perfil epidemiológico de la artritis reumatoide. Rev Med Inst Mex Seguro Soc.2023;61(5):574–582. doi:10.5281/zenodo.8316427. PMID: 37757464. PMCID: PMC10599789.
[4] Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Ou P, Li H, Luo X, Huang A, Pang Y. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022;13:1051082. doi:10.3389/fimmu.2022.1051082. PMID: 36618407; PMCID: PMC9817137.
[5] Sturgeon JA, Finan PH, Zautra AJ. Affective disturbance in rheumatoid arthritis: psychological and disease-related pathways. Nat Rev Rheumatol. 2016;12(9):532–542. doi:10.1038/nrrheum.2016.112. PMID: 27411910; PMCID: PMC5449457
[6] Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(12):2136–2148. PMID: 24003249
[7] Li YC, Chou YC, Chen HC, Lu CC, Chang DM. Interleukin-6 and interleukin-17 are related to depression in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(6):980–985. doi:10.1111/1756-185X.13529. PMID: 30848077
[8] Zhang C. Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: Shared common function and their possible applications in treatment (Review). Biomed Rep. 2021;14(1):16. doi:10.3892/br.2020.1392. PMID: 33269077; PMCID: PMC7694594.
[9] Michaud K, Pope J, van de Laar M, Curtis JR, Kannowski C, Mitchell S, Bell J, Workman J, Paik J, Cardoso A, Taylor PC. Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2020;72(10):1463–1476. doi:10.1002/acr.24369
[10] Kim JW, Suh CH. Systemic manifestations and complications in patients with rheumatoid arthritis. J Clin Med.2020;9(6):2008. doi:10.3390/jcm9062008. PMID: 32604884; PMCID: PMC7356332.
[11] Poletti S, Mazza MG, Benedetti F. Inflammatory mediators in major depression and bipolar disorder. Transl Psychiatry.2024;14:247. doi:10.1038/s41398-024-02921-z. PMID: 38851764; PMCID: PMC11162479.
[12] Corrigan M, O'Rourke AM, Moran B, Fletcher JM, Harkin A. Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin. Neuronal Signal. 2023 Jul 13;7(2):NS20220054. doi: 10.1042/NS20220054. PMID: 37457896; PMCID: PMC10345431.
[13] Choy EHS, Calabrese LH. Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis. Rheumatology (Oxford). 2018 Nov 1;57(11):1885-1895. doi: 10.1093/rheumatology/kex391. PMID: 29186541; PMCID: PMC6199533.
[14] Ionescu C-E, Popescu CC, Agache M, Dinache G, Codreanu C. Depression in Rheumatoid Arthritis: A Narrative Review—Diagnostic Challenges, Pathogenic Mechanisms and Effects. Medicina (Kaunas). 2022 Nov 13;58(11):1637. doi: 10.3390/medicina58111637.
[15] Fragoulis GE, Cavanagh J, Tindell A, Derakhshan M, Paterson C, Porter D, McInnes IB, Siebert S. Depression and anxiety in an early rheumatoid arthritis inception cohort: associations with demographic, socioeconomic, and disease features. RMD Open. 2020;6:e001376. doi: 10.1136/rmdopen-2020-001376.
[16] Meade T, Joyce C, Perich T, et al. Prevalence, severity, and measures of anxiety in rheumatoid arthritis: a systematic review. Arthritis Care Res (Hoboken). 2024;76(2):171–180. doi:10.1002/acr.25245.
[17] Ionescu C-E, Popescu C-C, Agache M, Dinache G, Codreanu C. Depression in rheumatoid arthritis: prevalence and effects on disease activity. J Clin Med. 2024 Apr 2;13(7):2058. doi: 10.3390/jcm13072058.
[18] Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology. 2011;50(2):401–409. doi: 10.1093/rheumatology/keq327.
[19] Qiu XJ, Zhang XL, Cai LS, et al. Rheumatoid arthritis and risk of anxiety: a meta-analysis of cohort studies. Clin Rheumatol. 2019;38(8):2053–2061. doi: 10.1007/s10067-019-04502-8.
[20] Meade T, Joyce C, Perich T, Manolios N, Conaghan PG, Katz P. Prevalence, severity, and measures of anxiety in rheumatoid arthritis: A systematic review. Arthritis Care Res (Hoboken). 2024;76(2):171–180. doi:10.1002/acr.25245. PMID: 37779491.
[21] Mena-Vázquez N, Ortiz-Márquez F, Ramírez-García T, et al. Impact of inflammation on cognitive function in patients with highly inflammatory rheumatoid arthritis. RMD Open. 2024;10:e004422. doi:10.1136/rmdopen-2024-004422
[22] Gwinnutt JM, Toyoda T, Jeffs S, et al. Reduced cognitive ability in people with rheumatoid arthritis compared with age-matched healthy controls. Rheumatol Adv Pract. 2021;5(2):rkab044. doi:10.1093/rap/rkab044.
[23] Lwin MN, Serhal L, Holroyd C, Edwards CJ. Rheumatoid arthritis: the impact of mental health on disease: a narrative review. Rheumatol Ther. 2020;7(3):457–471. doi:10.1007/s40744-020-00217-4.
[24] Ribeiro NPO, Schier AR, Ornelas AC, Pinho de Oliveira CM, Nardi AE, Silva AC. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs. Compr Psychiatry. 2013;54(6):514-519. doi: 10.1016/j.comppsych.2013.05.010.
[25] Deb A, Dwibedi N, LeMasters T, Hornsby JA, Wei W, Sambamoorthi U. Tumor necrosis factor inhibitor therapy and the risk for depression among working-age adults with rheumatoid arthritis. J Affect Disord. 2019;250:65-70. doi:10.1016/j.jad.2019.03.002. PMID: 30972151; PMCID: PMC6404801.
[26] Sun Y, Wang D, Salvadore G, Hsu B, Curran M, Casper C, Vermeulen J, Kent JM, Singh J, Drevets WC, Wittenberg GM, Chen G. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease. Brain Behav Immun. 2017;66:156-164. doi:10.1016/j.bbi.2017.06.014. PMID: 28676350.
[27] Nasereddin L, Alnajjar O, Bashar H, Abuarab SF, Al-Adwan R, Chellappan DK, Barakat M. Corticosteroid-induced psychiatric disorders: mechanisms, outcomes, and clinical implications. Int J Mol Sci. 2024;25(6):2643. doi:10.3390/ijms25062643. PMID: 39727630; PMCID: PMC11675195.
[28] Desilet LW, England BR, Michaud K, Barton JL, Mikuls TR, Baker JF. Posttraumatic stress disorder, depression, anxiety, and persistence of methotrexate and TNF inhibitors in patients with rheumatoid arthritis. ACR Open Rheumatol.2020;2(10):555–564. doi:10.1002/acr2.11175
[29] Nagy Z, Szigedi E, Takács S, Császár-Nagy N. The Effectiveness of Psychological Interventions for Rheumatoid Arthritis (RA): A Systematic Review and Meta-Analysis. PMID: 36984004. PMC10057722
[30] Keefe FJ, Somers TJ. Psychological approaches to understanding and treating arthritis pain. Nat Rev Rheumatol. 2010 Apr;6(4):210-6. doi:10.1038/nrrheum.2010.22.
[31] Felce D., Perry J. Quality of Life: Its Definition and Measurement. Res. Dev. Disabil. 1995;16:51–74. doi: 10.1016/0891-4222(94)00028-8.
[32] Riemsma R.P., Kirwan J.R., Taal E., Rasker H.J.J. Patient Education for Adults with Rheumatoid Arthritis. Cochrane Database Syst. Rev. 2003;2:CD003688. doi: 10.1002/14651858.CD003688.
[33] Maisiak R., Austin J.S., West S.G., Heck L. The Effect of Person-Centered Counseling on the Psychological Status of Persons with Systemic Lupus Erythematosus or Rheumatoid Arthritis: A Randomized, Controlled Trial. Arthritis Care Res. 1996;9:60–66. doi: 10.1002/art.1790090111
[34] Wu Z., Zhu Y., Wang Y., Zhou R., Ye X., Chen Z., Li C., Li J., Ye Z., Wang Z., et al. The Effects of Patient Education on Psychological Status and Clinical Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Front. Psychiatry. 2022;13:848427. doi: 10.3389/fpsyt.2022.848427.
[35] Savelkoul M., de Witte L., Post M. Stimulating Active Coping in Patients with Rheumatic Diseases: A Systematic Review of Controlled Group Intervention Studies. Patient Educ. Couns. 2003;50:133–143. doi: 10.1016/S0738-3991(02)00121-0
[36] Shen B., Li Y., Du X., Chen H., Xu Y., Li H., Xu G.-Y. Effects of Cognitive Behavioral Therapy for Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Psychol. Health Med. 2020;25:1179–1191. doi: 10.1080/13548506.2020.1736312.
[37] Prothero L, Barley E, Galloway J, Georgopoulou S, Sturt J. The evidence base for psychological interventions for rheumatoid arthritis: A systematic review of reviews. Int J Nurs Stud. 2018 Jun;82:20-29. doi: 10.1016/j.ijnurstu.2018.03.008.
[38] Astin JA, Beckner W, Soeken K, Hochberg MC, Berman B. Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthritis Rheum. 2002 Jun 15;47(3):291-302. doi: 10.1002/art.10416.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Monika Kaźmierczak, Oskar Tudaj, Wiktoria Kalas, Krzysztof Sajewicz, Julia Dulęba, Julia Kalisiak, Mikołaj Musiał, Maciej Hobot, Aleksandra Mazur, Filip Kin

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 78
Number of citations: 0